Healthcare provider profile · identity verified

Catherine Connell Hankla, DO

Family Practice · WINTER PARK, CO · NPI 1548688666

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	278	81
Atorvastatin Calcium	Atorvastatin Calcium	270	85
Lisinopril	Lisinopril	172	53
Amlodipine Besylate	Amlodipine Besylate	150	47
Losartan Potassium	Losartan Potassium	143	48
Omeprazole	Omeprazole	119	33
Tamsulosin Hcl	Tamsulosin Hcl	97	30
Gabapentin	Gabapentin	95	37
Simvastatin	Simvastatin	87	27
Metoprolol Succinate	Metoprolol Succinate	85	31
Metformin Hcl	Metformin Hcl	73	20
Rosuvastatin Calcium	Rosuvastatin Calcium	73	27
Fluoxetine Hcl	Fluoxetine Hcl	60	17
Zolpidem Tartrate	Zolpidem Tartrate	58	12
Allopurinol	Allopurinol	55	14
Hydrochlorothiazide	Hydrochlorothiazide	54	20
Pantoprazole Sodium	Pantoprazole Sodium	49	13
Trazodone Hcl	Trazodone Hcl	48	15
Estradiol	Estradiol	44	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	21
Finasteride	Finasteride	42	12
Eliquis	Apixaban	41	15
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Synthroid	Levothyroxine Sodium	39	11
Tramadol Hcl	Tramadol Hcl	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	13
Metoprolol Tartrate	Metoprolol Tartrate	36	11
Donepezil Hcl	Donepezil Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	13
Furosemide	Furosemide	33	18
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	31	11
Potassium Chloride	Potassium Chloride	31	14
Sertraline Hcl	Sertraline Hcl	30	12
Alendronate Sodium	Alendronate Sodium	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Prednisone	Prednisone	27	18
Meloxicam	Meloxicam	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Acyclovir	Acyclovir	25	11
Alprazolam	Alprazolam	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Ozempic	Semaglutide	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Bupropion Xl	Bupropion Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Famotidine	Famotidine	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error